Skip to main content
Fig. 1 | Breast Cancer Research

Fig. 1

From: Use of postmenopausal hormone therapies and risk of histology- and hormone receptor-defined breast cancer: results from a 15-year prospective analysis of NIH-AARP cohort

Fig. 1

Associations between estrogen-alone therapy (ET) at baseline and risk of breast cancer, by estrogen and progesterone receptor status and histology type, among eligible postmenopausal women with hysterectomy (n = 50,476) in the entire National Institutes of Health-AARP Diet and Health Study cohort (1996/1997–2011). BC, breast cancer. ER, estrogen receptor. PR, progesterone receptor

Back to article page